marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Applied Therapeutics Bilanz 2011-2024 | APLT
Bilanz Jährlich Applied Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-49.4 M | -15.8 M | -52.6 M | -55.1 M | -16.8 M | -18.7 M | -3.28 M | - | - | - | - | - | - |
Langfristige Schulden |
38 K | 414 K | 891 K | 1.33 M | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
429 K | 477 K | 442 K | 406 K | 356 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
797 K | 878 K | 891 K | 1.33 M | 1.68 M | - | 6.25 M | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
71.2 M | 33.4 M | 26.5 M | 21.2 M | 14.1 M | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
72 M | 34.3 M | 27.4 M | 22.6 M | 15.8 M | 4.43 M | 7.25 M | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
667 K | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-469 M | -349 M | -266 M | -161 M | -66.8 M | -21.3 M | -4.74 M | - | - | - | - | - | - |
Vermögenswerte |
54.8 M | 38.4 M | 89.9 M | 105 M | 48.4 M | 20.2 M | 3.29 M | - | - | - | - | - | - |
Zahlungsmittel |
49.9 M | 16.7 M | 53.9 M | 57.5 M | 18.8 M | 18.7 M | - | - | - | - | - | - | - |
Buchwert |
-17.1 M | 4.06 M | 62.5 M | 81.9 M | 32.6 M | 15.8 M | -3.96 M | - | - | - | - | - | - |
Gesamtes Eigenkapital |
-17.1 M | 4.06 M | 62.5 M | 81.9 M | 32.6 M | -19.6 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Applied Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
1.71 M | 30 K | 38 K | 44 K | 170 K | 291 K | 414 K | 536 K | 655 K | 773 K | 891 K | 1 M | 1.11 M | 1.22 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.68 M | 1.68 M | 1.68 M | 1.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
1.71 M | 30 K | 797 K | 735 K | 792 K | 825 K | 878 K | 536 K | 655 K | 773 K | 891 K | 1 M | 1.11 M | 1.22 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.68 M | 1.68 M | 1.68 M | 1.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
101 M | 55.4 M | 72 M | 56.2 M | 48 M | 34.1 M | 34.3 M | 47 M | 52.4 M | 23 M | 27.4 M | 31.8 M | 24.5 M | 21 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 4.43 M | 4.43 M | 4.43 M | 4.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
212 K | 333 K | 667 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-618 M | -550 M | -469 M | -431 M | -389 M | -359 M | -349 M | -334 M | -315 M | -289 M | -266 M | -239 M | -211 M | -185 M | -161 M | -161 M | -161 M | -161 M | -66.8 M | -66.8 M | -66.8 M | -66.8 M | -21.3 M | -21.3 M | -21.3 M | -21.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
107 M | 128 M | 54.8 M | 45.2 M | 43.6 M | 30 M | 38.4 M | 56.7 M | 78.2 M | 65 M | 89.9 M | 119 M | 137 M | 156 M | 105 M | 105 M | 105 M | 105 M | 48.4 M | 48.4 M | 48.4 M | 48.4 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
98.9 M | 122 M | 49.9 M | 37.5 M | 35.6 M | 22.9 M | 16.7 M | 40.4 M | 55.7 M | 38.2 M | 53.9 M | 70.2 M | 78.4 M | 84.1 M | 57.5 M | 57.5 M | 57.5 M | 57.5 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 3.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
5.89 M | 72.4 M | -17.1 M | -11 M | -4.33 M | -4.07 M | 4.06 M | 9.63 M | 25.8 M | 42 M | 62.5 M | 86.7 M | 112 M | 135 M | 81.9 M | 81.9 M | 81.9 M | 81.9 M | 32.6 M | 32.6 M | 32.6 M | 32.6 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
5.89 M | 72.4 M | -17.1 M | -11 M | -4.33 M | -4.07 M | 4.06 M | 9.63 M | 25.8 M | 42 M | 62.5 M | 86.7 M | 112 M | 135 M | 81.9 M | 81.9 M | 81.9 M | 81.9 M | 32.6 M | 32.6 M | 32.6 M | 32.6 M | -19.6 M | -19.6 M | -19.6 M | -19.6 M | -3.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung